Veru Inc.
VERU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000863894
In the last 90 days, Veru Inc. insiders filed 1 open-market purchase and 0 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $9.45M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Veru Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- +8 vs. Q2 2024
- Shares held
- 60.1M
- +7.03M (+13.2%) vs. Q2 2024
- Total value
- $46.2M
- +$1.54M (+3.4%) vs. Q2 2024
- New holders
- 17
- 37 more added
- Sold out
- 9
- 22 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $9.45M |
| Q1 2026 | 59 | $7.77M |
| Q4 2025 | 53 | $7.63M |
| Q3 2025 | 65 | $12.6M |
| Q2 2025 | 126 | $21.7M |
| Q1 2025 | 131 | $23.3M |
| Q4 2024 | 124 | $37.2M |
| Q3 2024 | 113 | $46.2M |
| Q2 2024 | 107 | $51.2M |
| Q1 2024 | 94 | $33.5M |
| Q4 2023 | 90 | $43.1M |
| Q3 2023 | 63 | $9.34M |
| Q2 2023 | 84 | $18.9M |
| Q1 2023 | 108 | $37.3M |
| Q4 2022 | 131 | $246.2M |
| Q3 2022 | 142 | $454.0M |
| Q2 2022 | 131 | $509.5M |
| Q1 2022 | 98 | $110.3M |
| Q4 2021 | 111 | $137.3M |
| Q3 2021 | 110 | $208.4M |
| Q2 2021 | 111 | $196.8M |
| Q1 2021 | 110 | $286.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Veru Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 1,057,904 | $813.5K | 0.00% | +750,832+244.5% | Added |
| Deutsche Bank AG | 1,101,296 | $848.0K | 0.00% | −2,641,618−70.6% | Reduced |
| Altium Capital Management LP | 2,028,534 | $1.56M | 0.46% | −248,158−10.9% | Reduced |
| State Street Corp | 2,072,065 | $1.59M | 0.00% | +84,483+4.3% | Added |
| Rosalind Advisors, Inc. | 2,694,503 | $2.07M | 1.37% | −1,500−0.1% | Reduced |
| Geode Capital Management, LLC | 2,940,140 | $2.26M | 0.00% | +131,720+4.7% | Added |
| Morgan Stanley | 3,014,633 | $2.32M | 0.00% | +221,009+7.9% | Added |
| Millennium Management LLC | 5,554,807 | $4.27M | 0.00% | +94,499+1.7% | Added |
| Vanguard Group Inc | 6,200,728 | $4.77M | 0.00% | +88,165+1.4% | Added |
| Perceptive Advisors LLC | 7,283,157 | $5.60M | 0.12% | +219,880+3.1% | Added |
| Adage Capital Partners GP, L.L.C. | 7,861,111 | $6.05M | 0.01% | 00.0% | Unchanged |
| BlackRock, Inc. | 8,235,270 | $6.33M | 0.00% | +8,235,270 | New |
| International Assets Investment Management, LLC | 691 | – | – | +691 | New |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −191,519−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −135,000−100.0% | Sold out |
| Mendel Capital Management LLC | 0 | $0 | 0.00% | −59,833−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −26,816−100.0% | Sold out |
| Kingswood Wealth Advisors, LLC | 0 | $0 | 0.00% | −24,800−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −97−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Gratus Capital LLC | – | – | – | – | Not filed |